🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kang Le

National Heart Lung and Blood Institute

ORCID: 0000-0002-1714-2377
MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Functional and multi-omics signatures of mitapivat efficacy upon activation of pyruvate kinase in red blood cells from patients with sickle cell disease”.

Functional and multi-omics signatures of mitapivat efficacy upon activation of pyruvate kinase in red blood cells from patients with sickle cell disease

Haematologica(2024)10.3324/haematol.2023.284831
N/A
0.538DataRank · unranked
12 citations

Kang Le, Maureen Lundt, Quan Li, Emily B. Dunkelberger, Troy Cellmer +9 more

Activating pyruvate kinase improves red blood cell integrity by reducing band 3 tyrosine phosphorylation

Blood Advances(2024)10.1182/bloodadvances.2024013504
N/A
0.461DataRank · unranked
15 citations

Xunde Wang, Jonathan M. Chu, Maureen Lundt, Yuan Yee Lee, Anna Conrey +9 more

Long-term mitapivat treatment is safe and efficacious in patients with sickle cell disease

Blood Red Cells & Iron(2025)10.1016/j.brci.2025.100014
N/A
0.256DataRank · unranked
4 citations

Nancy Asomaning, Ingrid Frey, Ruth Pierre Charles, Dianna Lovins, Julia Xu +13 more

JAK2 activation promotes tumorigenesis in ALK-negative anaplastic large cell lymphoma via regulating oncogenic STAT1-PVT1 lncRNA axis

Blood Cancer Journal(2021)10.1038/s41408-021-00447-x
N/A
0DataRank · unranked
6 citations

Linda Wellik, Matthew J. Maurer, Ellen D. McPhail, Thomas E. Witzig, Mamta Gupta +1 more

Dependence of peripheral T‐cell lymphoma on constitutively activated JAK3: Implication for JAK3 inhibition as a therapeutic approach

Hematological Oncology(2023)10.1002/hon.3233
N/A
0DataRank · unranked
2 citations

J Vollenweider, Jingjing Han, Nicholas Staudinger, Mary Stenson, Lara Bayraktar +6 more